Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting
NCT01053598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2013-02-20
Summary
The Principle objective of this study is To evaluate the performance of NRA, NRA-p and REMA-p for the detection of M. tuberculosis complex from sputum samples from adult pulmonary TB suspects in a high TB and HIV prevalence setting, using LJ and MGIT culture as gold standard.
The Secondary objectives are:
* To measure the performance of each assay (NRA, NRA-p, REMA-p) in sputum smear-negative patients
* To describe the results of the colorimetric methods in HIV-positive and HIV-negative patients
* To assess the time to detection of both NRA/NRA-p, REMA-p methods.
* To evaluate the feasibility of the NRA, NRA-p, REMA-p methods.
* To determine the rate of contamination of the NRA, NRA-p and REMA-p assays.
* To evaluate the proportion and the clinical relevance of NTM among TB suspects in a high TB and HIV prevalence setting.
* To provide capacity building for TB diagnosis in Mbarara.
Conditions
- Tuberculosis
- HIV
- AIDS
- HIV Infections
Sponsors & Collaborators
-
Mbarara University of Science and Technology
collaborator OTHER -
Medecins Sans Frontieres, Netherlands
collaborator OTHER -
Epicentre
lead OTHER
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-09-30
- Completion
- 2012-12-31
Countries
- Uganda
Study Locations
More Related Trials
-
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
NCT04618198 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA
NCT01640886 ·Status: TERMINATED
-
Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00846105 ·Status: COMPLETED ·Phase: NA
-
A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
NCT02684240 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives
NCT01184339 ·Status: COMPLETED
-
Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen
NCT00633009 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN
-
Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform
NCT04345939 ·Status: UNKNOWN
-
PK/PD of Ertapenem In Patients With TB
NCT01730664 ·Status: COMPLETED ·Phase: PHASE2
-
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
NCT06174649 ·Status: COMPLETED ·Phase: NA
-
INSPIRE Trial for Skin and Soft Tissue Infections
NCT05423756 ·Status: COMPLETED ·Phase: NA
-
Trial of MRSA Polymerase Chain Reaction for Pneumonia
NCT02660554 ·Status: COMPLETED ·Phase: NA
-
Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
NCT01601093 ·Status: SUSPENDED ·Phase: PHASE2
-
Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
NCT01498419 ·Status: COMPLETED ·Phase: PHASE2
-
Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide
NCT02120638 ·Status: UNKNOWN ·Phase: PHASE3
-
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
NCT00523926 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
NCT03338621 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dräger COVID-19 Antigen Test Clinical Performance Study
NCT04698993 ·Status: TERMINATED ·Phase: NA
-
PanACEA Sutezolid Dose-finding and Combination Evaluation
NCT03959566 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease
NCT05824988 ·Status: RECRUITING
-
A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections
NCT02355015 ·Status: UNKNOWN
-
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
NCT00980980 ·Status: COMPLETED ·Phase: NA
-
Nasal Swab Study to Explore the Nasal Microbia
NCT02535442 ·Status: COMPLETED
-
BacLite Rapid MRSA Clinical Performance
NCT00541632 ·Status: TERMINATED
-
A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients
NCT00002140 ·Status: COMPLETED ·Phase: PHASE3